A clinical trial to compare different modalities of Radiotherapy in reducing the acute treatment toxicities of patients with cancer cervix.

Randomized control trial to evaluate acute treatment related toxicities of 3-Dimensional Conformal Radiotherapy versus Intensity Modulated Radiotherapy in carcinoma cervix patients treated with concurrent chemoradiation

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2016/12/007545

Enrollment

Registered

2016-12-07

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients of Carcinoma Cervix

Interventions

Intervention1: INTENSITY MODULATED RADIOTHERAPY: CONTROL ARM - 3 DIMENSIONAL CONFORMAL RADIOTHERAPY INTERVENTIONAL ARM 1 - NON BONE MARROW SPARING INTENSITY MODULATED RADIOTHERAPY INTERVENTIONAL ARM 2

Eligibility

Inclusion criteria

Inclusion criteria: Karnofsky performance scale > 70 Age Haemoglobin > 10gm/dl TLC > 4000/cu mm Platelets > 1 lakh/cu mm Serum urea Serum creatinine < 1.2mg/dl

Exclusion criteria

Exclusion criteria: KPS All postoperative cases Evidence of any metastatic disease at any time before or during treatment Medical contraindications for concurrent chemotherapy Patient refusal to participate in the study Patients who have received chemoradiotherapy earlier Patients having any uncontrolled co morbid conditions

Design outcomes

Primary

Measure	Time frame
Evaluation of Acute ToxicitiesTimepoint: At the end of Brachytherapy	—

Secondary

Measure	Time frame
Local ControlTimepoint: At the end of one year	—

Countries

India

Contacts

Public ContactArun Elangovan

Postgraduate Institute of Medical Education and Research

dramitbahl@yahoo.com8195990813

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026